ClinicalTrials.govpublic full text
Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis
anterior uveitis, arthritis, juvenile idiopathic, iritis, immunosuppression, daclizumab, chronic inflammatory eye-disease, juvenile idiopathic arthritis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 848707
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.